Rockwell Medical, Inc. (RMTI) has a consensus analyst rating of Buy, based on 16 analysts covering the stock. Of those, 10 recommend buying, 2 recommend holding, and 4 recommend selling.
The analyst consensus price target for RMTI is $3.00, representing a +223.7% upside from the current price of $0.9269. Price targets range from a low of $3.00 to a high of $3.00.
